Is Lanreotide Really Useful in High Output Stoma? Comparison between Lanreotide to Conventional Antidiarrheal Treatment Alone
Background The incidence of high-output stoma (HOS) was reported to be approximately 3 to 16% in the literature, and HOS can cause dehydration. This complication is often severe enough to warrant hospital readmission and may result in renal failure. The aim of this study was to show a decrease of 50...
Main Authors: | Yannis Mesli, Lise Holterbach, Jean-Baptiste Delhorme, Zaher Lakkis, Pablo Ortega-Deballon, Sophie Deguelte, Serge Rohr, Cécile Brigand, Nicolas Meyer, Benoit Romain |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-11-01
|
Series: | Journal of Investigative Surgery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08941939.2020.1800871 |
Similar Items
-
The Use of Lanreotide Autogel® in the Treatment of Intestinal Obstruction in a Patient with Adenocarcinoma
by: Willem Lybaert
Published: (2014-01-01) -
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
by: Keiko Yamaoka, et al.
Published: (2021-05-01) -
Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN)
by: Zhenmei An, et al.
Published: (2020-05-01) -
Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel
by: Gema Marín Zafra, et al.
Published: (2016-01-01) -
Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa
by: Daleen Geldenhuys, et al.
Published: (2020-10-01)